Search

Your search keyword '"Claudia García-Morales"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Claudia García-Morales" Remove constraint Author: "Claudia García-Morales"
43 results on '"Claudia García-Morales"'

Search Results

1. Unveiling ecological/evolutionary insights in HIV viral load dynamics: Allowing random slopes to observe correlational changes to CpG-contents and other molecular and clinical predictors

2. Honduras HIV cohort: HLA class I and CCR5-Δ32 profiles and their associations with HIV disease outcome

3. HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay—Results of a Nationally Representative Survey, 2018–2019

4. Retention in Care, Mortality, Loss-to-Follow-Up, and Viral Suppression among Antiretroviral Treatment-Naïve and Experienced Persons Participating in a Nationally Representative HIV Pre-Treatment Drug Resistance Survey in Mexico

5. HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020

6. Evolutionary history and spatiotemporal dynamics of the HIV-1 subtype B epidemic in Guatemala.

7. High HPgV replication is associated with improved surrogate markers of HIV progression.

8. HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015.

9. HIV-1 Antiretroviral Drug Resistance Mutations in Treatment Naïve and Experienced Panamanian Subjects: Impact on National Use of EFV-Based Schemes.

10. HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy.

11. Human immunodeficiency virus type 1 (HIV-1) subtype B epidemic in Panama is mainly driven by dissemination of country-specific clades.

12. Molecular epidemiology of HIV-1 in Panama: origin of non-B subtypes in samples collected from 2007 to 2013.

14. National prevalence and trends of HIV transmitted drug resistance in Mexico.

15. Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study (Seroincidence)

16. Simultaneous monitoring of HIV viral load and screening of SARS-CoV-2 employing a low-cost RT-qPCR test workflow

17. PrEPvenir la infección por VIH

18. High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019

19. Phylodynamics of HIV in the Mexico City Metropolitan Region

20. HIV drug resistance in persons initiating or reinitiating first-line antiretroviral therapy in Paraguay: Results of a National Patient Survey

21. Dynamics and Dispersal of Local Human Immunodeficiency Virus Epidemics Within San Diego and Across the San Diego–Tijuana Border

22. Inexpensive workflow for simultaneous monitoring of HIV viral load and detection of SARS-CoV-2 infection

23. Characteristics and growth of the genetic HIV transmission network of Mexico City during 2020

24. Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort

25. HIV pretreatment drug resistance trends in three geographic areas of Mexico

26. High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17

27. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016

28. Pretreatment HIV-drug resistance in Mexico and its impact on the effectiveness of first-line antiretroviral therapy: a nationally representative 2015 WHO survey

29. Killer cell immunoglobulin-like receptor and human leukocyte antigen gene profiles in a cohort of HIV-infected Mexican Mestizos

30. HIV-1 drug resistance before initiation or re-initiation of first-line ART in eight regions of Mexico: a sub-nationally representative survey

31. Novel HLA class I associations with HIV-1 control in a unique genetically admixed population

32. Identification of major routes of HIV transmission throughout Mesoamerica

33. Weaker HLA Footprints on HIV in the Unique and Highly Genetically Admixed Host Population of Mexico

34. High HPgV replication is associated with improved surrogate markers of HIV progression

35. Prevalence and patterns of HIV transmitted drug resistance in Guatemala Prevalencia y patrones de farmacorresistencia transmitida del VIH en Guatemala

36. HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015

37. O331: HIV drug resistance in treatment-naïve individuals in Mesoamerica

38. HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral Therapy

39. Transmitted Drug Resistance and HIV Molecular Epidemiology in Nicaragua

40. Impact of HLA-B*35 subtype differences on HIV disease outcome in Mexico

41. Human immunodeficiency virus type 1 (HIV-1) subtype B epidemic in Panama is mainly driven by dissemination of country-specific clades

42. Prevalence and patterns of HIV transmitted drug resistance in Guatemala

43. Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study

Catalog

Books, media, physical & digital resources